Next generation vaccines and vectors: Designing downstream processes for recombinant protein‐based virus‐like particles
Authors:
- 16 April 2015
- journal article
- review article
- Published by Wiley in Biotechnology Journal
- Vol. 10 (5) , 715-727
Abstract
In recent years, the development of novel recombinant virus‐like particles (VLPs) has been generating new perspectives for the prevention of untreated and arising infectious diseases. However, cost‐reduction and acceleration of manufacturing processes for VLP‐based vaccines or vectors are key challenges for the global health system. In particular, the design of rapid and cost‐efficient purification processes is a critical bottleneck. In this review, we describe and evaluate new concepts, development strategies and unit operations for the downstream processing of VLPs. A special focus is placed on purity requirements and current trends, as well as chances and limitations of novel technologies. The discussed methods and case studies demonstrate the advances and remaining challenges in both rational process development and purification tools for large biomolecules. The potential of a new era of VLP‐based products is highlighted by the progress of various VLPs in clinical phases.Keywords
This publication has 149 references indexed in Scilit:
- Effective Chikungunya Virus-like Particle Vaccine Produced in Insect CellsPLOS Neglected Tropical Diseases, 2013
- Immunogenicity of HIV Virus-Like Particles in Rhesus Macaques by Intranasal AdministrationClinical and Vaccine Immunology, 2012
- Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivityVirology Journal, 2012
- On the Effect of Thermodynamic Equilibrium on the Assembly Efficiency of Complex Multi-Layered Virus-Like Particles (VLP): the Case of Rotavirus VLPPLOS Computational Biology, 2012
- Safety and immunogenicity of a candidate parvovirus B19 vaccineVaccine, 2011
- Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the Hepatitis B surface antigenMicrobial Cell Factories, 2011
- Structure of Hepatitis E Virion-sized Particle Reveals an RNA-dependent Viral Assembly Pathway*Journal of Biological Chemistry, 2010
- Norwalk Virus Assembly and Stability Monitored by Mass SpectrometryMolecular & Cellular Proteomics, 2010
- HPV Vaccines: Preclinical DevelopmentArchives of Medical Research, 2009
- Inactivation and purification of cowpea mosaic virus-like particles displaying peptide antigens from Bacillus anthracisJournal of Virological Methods, 2007